New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improved anticancer efficacy

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
   PubMed Web of Science ®Google Scholar
• Wicki A, Witzigmann D, Balasubramanian V, et al. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release. 2015;200:138–157.
   PubMed Web of Science ®Google Scholar
• Vijay M, Anu Y. Anticancer activity of camellia sinensis mediated copper nanoparticles against HT-29, MCF-7, and MOLT-4 human cancer cell lines. Asian J Pharm Clin Res. 2017;10:82–88.
   Google Scholar
• Hussain Z, Thu HE, Katas H, et al. Hyaluronic acid-based biomaterials: a versatile and smart approach to tissue regeneration and treating traumatic, surgical, and chronic wounds. Polym Rev. 2017;57:594–630.
   Web of Science ®Google Scholar
• Ganesh S, Iyer AK, Morrissey DV, et al. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors. Biomaterials. 2013;34:3489–3502.
   PubMed Web of Science ®Google Scholar
• Kong Q, Liu J, Chen X, et al. Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder. Oncol Rep. 2003;10:51–55.
   PubMed Web of Science ®Google Scholar
• Yang Z, Luo H, Cao Z, et al. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer. Nanoscale. 2016;8:11543–11558.
   PubMed Web of Science ®Google Scholar
• Hu S, Wu X, Zhou B, et al. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. J Cancer Res Clin Oncol. 2014;140:883–893.
   PubMed Web of Science ®Google Scholar
• Motohara T, Fujimoto K, Tayama S, et al. CD44 variant 6 as a predictive biomarker for distant metastasis in patients with epithelial ovarian cancer. Obstet Gynecol. 2016;127:1003–1010.
   PubMed Web of Science ®Google Scholar
• Hirata K, Suzuki H, Imaeda H, et al. CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence. Br J Cancer. 2013;109:379–386.
   PubMed Web of Science ®Google Scholar
• Todaro M, Gaggianesi M, Catalano V, et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell. 2014;14:342–356.
   PubMed Web of Science ®Google Scholar
• Zhao P, Damerow MS, Stern P, et al. CD44 promotes Kras-dependent lung adenocarcinoma. Oncogene. 2013;32:5186–5190.
   PubMed Web of Science ®Google Scholar
• Bourguignon LYW, Peyrollier K, Xia W, et al. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem. 2008;283:17635–17651.
   PubMed Web of Science ®Google Scholar
• Chen L, Bourguignon LY. Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells. Mol Cancer. 2014;13:52.
   PubMed Web of Science ®Google Scholar
• Serafino G, Zonfrillo M, Andreola F, et al. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan biconjugate for locoregional treatment of peritoneal carcinomatosis. Curr Cancer Drug Targets. 2011;11:572–585.
   PubMed Web of Science ®Google Scholar
• Mattheolabakis G, Milane L, Singh A, et al. Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. J Drug Target. 2015;23:605–618.
   PubMed Web of Science ®Google Scholar
• Li J, He Y, Sun W, et al. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging. Biomaterials. 2014;35:3666–3677.
   PubMed Web of Science ®Google Scholar
• Xiong Q, Cui M, Bai Y, et al. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma. Colloids Surf B Biointerfaces. 2017;155:93–103.
   PubMed Web of Science ®Google Scholar
• Hsu SH, Hsieh CT, Sun YM. Synthesis and characterization of waterborne polyurethane containing poly(3-hydroxybutyrate) as new biodegradable elastomers. J Mater Chem B. 2015;3:9089–9097.
   PubMed Web of Science ®Google Scholar
• Li J, Hu Y, Sun W, et al. Facile preparation of hyaluronic acid-modified Fe3O4@Mn3O4 nanocomposites for targeted T1/T2 dual-mode MR imaging of cancer cells. RSC Adv. 2016;6:35295–35304.
   Web of Science ®Google Scholar
• Chen C, Zhou B, Zhu X, et al. Branched polyethyleneimine modified with hyaluronic acid via a PEG spacer for targeted anticancer drug delivery. RSC Adv. 2016;6:9232–9239.
   Web of Science ®Google Scholar
• Cao X, Tao L, Wen S, et al. Hyaluronic acid-modified multi-walled carbon nanotubes for targeted delivery of doxorubicin into cancer cells. Carbohydr Res. 2015;405:70–77.
   PubMed Web of Science ®Google Scholar
• Li J, Hu Y, Yang J, et al. Hyaluronic acid-modified Fe3O4@Au core/shell nanostars for multimodal imaging and photothermal therapy of tumors. Biomaterials. 2015;38:10–21.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang T, Mu S, et al. Biomacromolecule/lipid hybrid nanoparticles for controlled delivery of sorafenib in targeting hepatocellular carcinoma therapy. Nanomedicine (Lond). 2017;12:911–925.
   PubMed Web of Science ®Google Scholar
• Wang R, Luo Y, Yang S, et al. Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma. Sci Rep. 2016;6:33844.
   PubMed Web of Science ®Google Scholar
• Mezghrani O, Tang Y, Ke X, et al. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin. Int J Pharm. 2015;478:553–568.
   PubMed Web of Science ®Google Scholar
• Xu C, Ding Y, Ni J, et al. Tumor-targeted docetaxel-loaded hyaluronic acid-quercetin polymeric micelles with p-gp inhibitory property for hepatic cancer therapy. RCS Adv. 2016;6:27542–27556.
   Web of Science ®Google Scholar
• Yang C, Wang X, Yao X, et al. Hyaluronic acid nanogels with enzyme-sensitive cross-linking group for drug delivery. J Control Release. 2015;205:206–217.
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhang Z, Zhang Y, et al. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials. 2012;33:9246–9258.
   PubMed Web of Science ®Google Scholar
• Jeong JY, Hong EH, Lee SY, et al. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration. Acta Biomater. 2017;53:414–426.
   PubMed Web of Science ®Google Scholar
• Wang F, Li L, Liu B, et al. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. Biomed Pharmacother. 2017;86:595–604.
   PubMed Web of Science ®Google Scholar
• Ding J, Liang T, Zhou Y, et al. Hyaluronidase-triggered anticancer drug and siRNA delivery from cascaded targeting nanoparticles for drug-resistant breast cancer therapy. Nano Res. 2017;10:690–703.
   Web of Science ®Google Scholar
• Hwang DW, Kim HY, Li F, et al. In vivo visualization of endogenous miR-21 using hyaluronic acid-coated graphene oxide for targeted cancer therapy. Biomaterials. 2017;121:144–154.
   PubMed Web of Science ®Google Scholar
• Cerqueira BBS, Lasham A, Shellingc AN, et al. Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells. Mater Sci Eng C Mater Biol Appl. 2017;76:593–600.
   PubMed Web of Science ®Google Scholar
• Zheng S, Jin Z, Han J, et al. Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake. Colloids Surf B Biointerfaces. 2016;143:27–36.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Goltsche K, Cheng L, et al. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Biomaterials. 2016;84:250–261.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li J, Pu G, et al. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy. Drug Deliv. 2016;23:1364–1368.
   PubMed Web of Science ®Google Scholar
• Ran R, Liu Y, Gao H, et al. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy. J Pharm Sci. 2015;104:476–484.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang J, Wang Y, et al. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Nanomedicine. 2016;12:411–420.
   PubMed Web of Science ®Google Scholar
• Jian YS, Chen CW, Lin CA, et al. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo. Int J Nanomed. 2017;12:2315–2333.
   PubMedGoogle Scholar
• Singh SP, Sharma M, Gupta PK. Cytotoxicity of curcumin silica nanoparticle complexes conjugated with hyaluronic acid on colon cancer cells. Int J Biol Macromol. 2015;74:162–170.
   PubMed Web of Science ®Google Scholar
• Choi KY, Yoon HY, Kim JH, et al. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano. 2011;5:8591–8599.
   PubMed Web of Science ®Google Scholar
• Yoon HY, Koo H, Choi KY, et al. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials. 2012;33:3980–3989.
   PubMed Web of Science ®Google Scholar
• Lu Z, Su J, Li Z, et al. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy. Drug Dev Ind Pharm. 2017;43:160–170.
   PubMed Web of Science ®Google Scholar
• Saneja A, Nayak D, Srinivas M, et al. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Eur J Pharm Sci. 2017;97:79–91.
   PubMed Web of Science ®Google Scholar
• Nigam Joshi P, Agawane S, Athalye MC, et al. Multifunctional inulin tethered silver-graphene quantum dots nanotheranostic module for pancreatic cancer therapy. Mater Sci Eng C Mater Biol Appl. 2017;78:1203–1211.
   PubMed Web of Science ®Google Scholar
• Su MJ, Aldawsari H, Amiji M. Pancreatic cancer cell exosome-mediated macrophage reprogramming and the role of microRNAs 155 and 125b2 transfection using nanoparticle delivery systems. Sci Rep. 2016;6:30110.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Xie L, Banerjee S, et al. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Colloids Surf B Biointerfaces. 2015;136:413–423.
   PubMed Web of Science ®Google Scholar
• Yan H, Song J, Jia X, et al. Hyaluronic acid-modified didecyldimethylammonium bromide/d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluation. Drug Deliv. 2017;24:30–39.
   PubMed Web of Science ®Google Scholar
• Park KE, Noh YW, Kim A, et al. Hyaluronic acid-coated nanoparticles for targeted photodynamic therapy of cancer guided by near-infrared and MR imaging. Carbohydr Polym. 2017;157:476–483.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang Y, Yu D. Lung cancer gene therapy: transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery. Oncol Rep. 2016;37:937–944.
   PubMed Web of Science ®Google Scholar
• Luo Y, Wang X, Du D, et al. Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery. Biomater Sci. 2015;3:1386–1394.
   PubMed Web of Science ®Google Scholar
• Wu J, Deng C, Meng F, et al. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer. J Control Release. 2017;259:76–82.
   PubMed Web of Science ®Google Scholar
• Luo Y, Cai X, Li H, et al. Hyaluronic acid-modified multifunctional Q-graphene for targeted killing of drug-resistant lung cancer cells. ACS Appl Mater Interfaces. 2016;8:4048–4055.
   PubMed Web of Science ®Google Scholar
• Ganesh S, Iyer AK, Gattacceca F, et al. In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles. J Control Release. 2013;172:699–706.
   PubMed Web of Science ®Google Scholar
• Jiang BP, Zhang L, Guo XL, et al. Poly(N-phenylglycine)-based nanoparticles as highly effective and targeted near-infrared photothermal therapy/photodynamic therapeutic agents for malignant melanoma. Small. 2017;13:1602496.
   Web of Science ®Google Scholar
• Deng C, Zhang Q, Fu Y, et al. Coadministration of oligomeric hyaluronic acid-modified liposomes with tumor-penetrating peptide-iRGD enhances the antitumor efficacy of doxorubicin against melanoma. ACS Appl Mater Interfaces. 2017;9:1280–1292.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Li H, Wang K, et al. Bioreducible cross-linked hyaluronic acid/calcium phosphate hybrid nanoparticles for specific delivery of siRNA in melanoma tumor therapy. ACS Appl Mater Interfaces. 2017;9:14576–14589.
   PubMed Web of Science ®Google Scholar
• Shen H, Shi S, Zhang Z, et al. Coating solid lipid nanoparticles with hyaluronic acid enhances antitumor activity against melanoma stem-like cells. Theranostics. 2015;5:755–771.
   PubMed Web of Science ®Google Scholar
• Jung HS, Kong WH, Sung DK, et al. Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer. ACS Nano. 2014;8:260–268.
   PubMed Web of Science ®Google Scholar
• Montanari E, Capece S, Di Meo C, et al. Hyaluronic acid nanohydrogels as a useful tool for BSAO immobilization in the treatment of melanoma cancer cells. Macromol Biosci. 2013;13:1185–1194.
   PubMed Web of Science ®Google Scholar
• Shi J, Ma R, Wang L, et al. The application of hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatment. Int J Nanomed. 2013;8:2361–2373.
   PubMed Web of Science ®Google Scholar
• Yao J, Zhang L, Zhou J, et al. Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and Paclitaxel based on hyaluronic acid-based multifunctional nanocarrier. Mol Pharm. 2013;10:1080–1091.
   PubMed Web of Science ®Google Scholar
• Yang X, Iyer AK, Singh A, et al. MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer. Sci Rep. 2015;5:8509.
   PubMed Web of Science ®Google Scholar
• Liu E, Zhou Y, Liu Z, et al. Cisplatin loaded hyaluronic acid modified TiO2 nanoparticles for neoadjuvant chemotherapy of ovarian cancer. J Nanomater. 2015;2015:390358.
   Web of Science ®Google Scholar
• Wang L, Jia E. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance. Drug Deliv. 2016;23:1810–1817.
   PubMed Web of Science ®Google Scholar
• Jing L, Shao S, Wang Y, et al. Hyaluronic acid modified hollow prussian blue nanoparticles loading 10-hydroxycamptothecin for targeting thermochemotherapy of cancer. Theranostics. 2016;6:40–53.
   PubMed Web of Science ®Google Scholar
• Jiang BP, Zhang L, Zhu Y, et al. Water-soluble hyaluronic acid–hybridized polyaniline nanoparticles for effectively targeted photothermal therapy. J Mater Chem B. 2015;3:3767–3776.
   PubMed Web of Science ®Google Scholar
• Zhang L, Gao S, Zhang F, et al. Activatable hyaluronic acid nanoparticle as a theranostic agent for optical/photoacoustic image-guided photothermal therapy. ACS Nano. 2014;8:12250–12258.
   PubMed Web of Science ®Google Scholar
• Thomas RG, Moon M, Lee S, et al. Paclitaxel loaded hyaluronic acid nanoparticles for targeted cancer therapy: in vitro and in vivo analysis. Int J Biol Macromol. 2015;72:510–518.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Yoon HY, Koo H, et al. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis. J Control Release. 2012;162:111–118.
   PubMed Web of Science ®Google Scholar
• Qu CY, Zhou M, Chen YW, et al. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy. Int J Nanomed. 2015;10:3911–3920.
   PubMed Web of Science ®Google Scholar
• Yao HJ, Zhang YG, Sun L, et al. The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells. Biomaterials. 2014;35:9208–9223.
   PubMed Web of Science ®Google Scholar
• Choi KY, Jeon EJ, Yoon HY, et al. Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer. Biomaterials. 2012;33:6186–6193.
   PubMed Web of Science ®Google Scholar
• Mackay CR, Terpe HJ, Stauder R, et al. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol. 1994;124:71–82.
   PubMed Web of Science ®Google Scholar